Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Biofilms provide refuge for cancerous bacteria: Familial adenomatous polyposis (FAP) causes benign polyps along the colon. If left untreated, FAP leads to a high incidence of colon cancer. To understand how polyps influence tumor formation, Dejea et al. examined the colonic mucosa of FAP patients. They discovered biofilms containing the carcinogenic versions of the bacterial species Escherichia coli and Bacteroides fragilis . Colon tissue from FAP patients exhibited greater expression of two bacterial genes that produce secreted oncotoxins. Studies in mice showed that specific bacteria could work together to induce colon inflammation and tumor formation. Science , this issue p. 592
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“intratumor microbes have been reported to have cancer-specific effects on (i) gastrointestinal and urinary tract mutagenesis via secreted genotoxins, most notably pks+ E. coli-derived colibactin and B. fragilis-derived toxin (22, 37, 38, 40, 41)”
From The microbiome and human cancer (2021) · cites this paper as [38]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“They affect gastrointestinal and urinary tract mutagenesis by secreting genotoxins [411, 412, 413]”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [412]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These pks-positive E. coli strains have been detected in approximately 20% of healthy individuals, 40% of patients with inflammatory bowel disease, and 60% of patients with CRC”
From Selection, Comparative Genomics, and Potential Probiotic Features of Escherichia coli 5C, a pks-Negative Strain Isolated from Healthy Infant Donor Feces (2026) · cites this paper as [154]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Increasing evidence suggests an important additional category of “complicit” microbes and microbial functions that promote carcinogenesis but are insufficient to cause cancer (18, 20, 25, 38, 44–47).”
From The microbiome and human cancer (2021) · cites this paper as [38]
In the citing paper
“Higher proportions of patients with familial adenomatous polyposis42 or sporadic premalignant lesions had intestinal mucosa that tested positive for ETBF than of controls.41”
From Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer (2020) · cites this paper as [42]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Intestinal inflammation targets cancer-inducing activity of the microbiota
Arthur, J. C., Perez-Chanona, E., Mühlbauer, M., Tomkovich, S., Uronis, J. M., Fan, T.-J., Campbell, B. J., Abujamel, T., Dogan, B., Rogers, A. B., et al. (2012) · Science · doi:10.1126/science.1224820 · Cited by 2,263
Wu, S., Rhee, K.-J., Albesiano, E., Rabizadeh, S., Wu, X., Yen, H.-R., Huso, D. L., Brancati, F. L., Wick, E., McAllister, F., et al. (2009) · Nature Medicine · doi:10.1038/nm.2015 · Cited by 1,812
Self-citationMicrobiota organization is a distinct feature of proximal colorectal cancers
Dejea, C. M., Wick, E. C., Hechenbleikner, E. M., White, J. R., Mark Welch, J. L., Rossetti, B. J., Peterson, S. N., Snesrud, E. C., Borisy, G. G., Lazarev, M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406199111 · Cited by 700
Self-citationThe Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients
Boleij, A., Hechenbleikner, E. M., Goodwin, A. C., Badani, R., Stein, E. M., Lazarev, M. G., Ellis, B., Carroll, K. C., Albesiano, E., Wick, E. C., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu787 · Cited by 625
Self-citationComparative study of the intestinal mucus barrier in normal and inflamed colon
Swidsinski, A., Loening-Baucke, V., Theissig, F., Engelhardt, H., Bengmark, S., Koch, S., Lochs, H., & Dorffel, Y. (2007) · Gut · doi:10.1136/gut.2006.098160 · Cited by 365
Metabolism Links Bacterial Biofilms and Colon Carcinogenesis
Johnson, C. H., Dejea, C. M., Edler, D., Hoang, L. T., Santidrian, A. F., Felding, B. H., Ivanisevic, J., Cho, K., Wick, E. C., Hechenbleikner, E. M., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.04.011 · Cited by 351
Self-citationRhee, K.-J., Wu, S., Wu, X., Huso, D. L., Karim, B., Franco, A. A., Rabizadeh, S., Golub, J. E., Mathews, L. E., Shin, J., et al. (2009) · Infection and Immunity · doi:10.1128/iai.00814-08 · Cited by 297
Self-citationProrok-Hamon, M., Friswell, M. K., Alswied, A., Roberts, C. L., Song, F., Flanagan, P. K., Knight, P., Codling, C., Marchesi, J. R., Winstanley, C., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-304739 · Cited by 236
Bacteroides fragilis Enterotoxin Gene Sequences in Patients with Inflammatory Bowel Disease
Prindiville, T. P., Sheikh, R. A., Cohen, S. H., Tang, Y. J., Cantrell, M. C., & Silva, J. (2000) · Emerging Infectious Diseases · doi:10.3201/eid0602.000210 · Cited by 199
Research works printed but not linked: 1
- Swidsinski A Loening-Baucke V Herber A J Physiol Pharmacol 60 suppl 6 61 71 2009 20224153
Cited by
Items 201–300 of 999
Influence of gut and intratumoral microbiota on the immune microenvironment and anti-cancer therapy
Chen, Y., Liu, B., Wei, Y., & Kuang, D.-M. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105966 · Cited by 73
Potential Impacts of Prebiotics and Probiotics on Cancer Prevention
Samanta, S. (2020) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520621999201210220442 · Cited by 83
Beyond the Gut: The intratumoral microbiome's influence on tumorigenesis and treatment response
Zhang, H., Fu, L., Leiliang, X., Qu, C., Wu, W., Wen, R., Huang, N., He, Q., Cheng, Q., Liu, G., et al. (2024) · 癌症:英文版 · doi:10.1002/cac2.12597 · Cited by 78
“E. coli can invade the colonic mucus layer, colonize polyps (precancerous lesions), and encode for colibactins, an unstable DNA alkylating agent [133].”
BackgroundMicrobe-based therapies for colorectal cancer: Advantages and limitations
Saeed, M., Shoaib, A., Kandimalla, R., Javed, S., Almatroudi, A., Gupta, R. C., & Aqil, F. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.05.018 · Cited by 75
Tibbs, T. N., Lopez, L. R., & Arthur, J. C. (2019) · Microbial Cell · doi:10.15698/mic2019.08.685 · Cited by 68
“beyond the capability that either species has individually [94].”
BackgroundWhat is the role of meat in a healthy diet?
Klurfeld, D. M. (2018) · Animal Frontiers · doi:10.1093/af/vfy009 · Cited by 68
Kasper, S. H., Morell-Perez, C., Wyche, T. P., Sana, T. R., Lieberman, L. A., & Hett, E. C. (2020) · Scientific Reports · doi:10.1038/s41598-020-62139-z · Cited by 77
Host responses to mucosal biofilms in the lung and gut
Domingue, J. C., Drewes, J. L., Merlo, C. A., Housseau, F., & Sears, C. L. (2020) · Mucosal Immunology · doi:10.1038/s41385-020-0270-1 · Cited by 67
Self-citationZhu, R., Lang, T., Yan, W., Zhu, X. G., Huang, X. Y., Yin, Q., & Li, Y. (2021) · Advanced Science · doi:10.1002/advs.202003542 · Cited by 68
Intestinal microbiota: a novel perspective in colorectal cancer biotherapeutics
Ding, C., Tang, W., Fan, X., & Wu, G. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s170626 · Cited by 69
“fragilis (ETBF) and Escherichia coli (expressing colibactin) showed increased levels of inflammation markers in the colon and DNA damage in colonic epithelium with faster tumor onset and greater mortality, compared to mice with either bacterial strain alone.(21) Mechanistically, gut microbiota may induce CRC by numero…”
Reactivity of an Unusual Amidase May Explain Colibactin’s DNA Cross-Linking Activity
Jiang, Y., Stornetta, A., Villalta, P. W., Wilson, M. R., Boudreau, P. D., Zha, L., Balbo, S., & Balskus, E. P. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.9b02453 · Cited by 71
Xue, M., Liang, H. W., Ji, X., Zhou, Z., Liu, Y., Sun, T., & Zhang, L. (2020) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2020.108396 · Cited by 72
Taylor, J. C., Gao, X., Xu, J., Holder, M., Petrosino, J. F., Kumar, R., Liu, W., Höök, M., Mackenzie, C., Hillhouse, A., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009182 · Cited by 67
Tumor associated macrophage and microbe: The potential targets of tumor vaccine delivery
Jiang, J., Mei, J., Yi, S., Feng, C., Ma, Y., Liu, Y., Liu, Y., & Chen, C. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114046 · Cited by 72
Broadening oncological boundaries: the intratumoral microbiota
Lu, Y.-Q., Qiao, H., Tan, X.-R., & Liu, N. (2024) · Trends in Microbiology · doi:10.1016/j.tim.2024.01.007 · Cited by 66
Wei, X., Wang, F., Tan, P., Huang, H., Wang, Z., Xie, J., Wang, L., Liu, D., & Hu, Z. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107148 · Cited by 77
Flow-Induced Symmetry Breaking in Growing Bacterial Biofilms
Pearce, P., Song, B., Skinner, D. J., Mok, R. V., Hartmann, R., Singh, P. K., Jeckel, H., Oishi, J. S., Drescher, K., & Dunkel, J. (2019) · Physical Review Letters · doi:10.1103/physrevlett.123.258101 · Cited by 60
Gut mycobiome: A promising target for colorectal cancer
Qin, X., Gu, Y., Liu, T., Wang, C., Zhong, W., Wang, B., & Cao, H. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188489 · Cited by 66
Human Gut Microbiota in Health and Selected Cancers
Sędzikowska, A., & Szablewski, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413440 · Cited by 78
Yuan, L., Pan, L., Wang, Y., Zhao, J., Fang, L., Zhou, Y., Xia, R., Ma, Y., Jiang, Z., Xu, Z., et al. (2024) · Cell Discovery · doi:10.1038/s41421-024-00746-0 · Cited by 74
“These fi ndings align with the observed poorer overall survival outcomes (Fig.”
Epigenetic Changes Induced by Bacteroides fragilis Toxin
Allen, J., Hao, S., Sears, C. L., & Timp, W. (2019) · Infection and Immunity · doi:10.1128/iai.00447-18 · Cited by 76
“CEACAM6 acts as a receptor for adherent-invasive E. coli, an E. coli phenotype implicated in ileal inflammatory bowel disease (29) as well as the development/progression of CRC in individuals with familial adenomatous polyposis (FAP) (17) and sporadic CRC (30).”
BackgroundInfluentialSelf-citationGu, S., Zaidi, S., Hassan, M. I., Mohammad, T., Malta, T. M., Noushmehr, H., Nguyen, B., Crandall, K. A., Srivastav, J., Obias, V., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.09.023 · Cited by 63
Malaria and the Microbiome: A Systematic Review
Ippolito, M. M., Denny, J. E., Langelier, C., Sears, C. L., & Schmidt, N. W. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy374 · Cited by 66
Self-citationColon Cancer: From Epidemiology to Prevention
Katsaounou, K., Nicolaou, E., Vogazianos, P., Brown, C., Stavrou, M., Teloni, S., Hatzis, P., Agapiou, A., Fragkou, E., Tsiaoussis, G. I., et al. (2022) · Metabolites · doi:10.3390/metabo12060499 · Cited by 76
Active thrombin produced by the intestinal epithelium controls mucosal biofilms
Motta, J., Denadai‐Souza, A., Sagnat, D., Guiraud, L., Edir, A., Bonnart, C., Sebbag, M., Rousset, P., Lapeyre, A., Séguy, C., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11140-w · Cited by 70
The effects of diet and gut microbiota on the regulation of intestinal mucin glycosylation
Qu, D., Wang, G., Yu, L., Tian, F., Chen, W., & Zhai, Q. (2021) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2021.117651 · Cited by 71
A systemic review of the role of enterotoxic Bacteroides fragilis in colorectal cancer
Scott, N. E., Whittle, E., Jeraldo, P., & Chia, N. (2022) · Neoplasia · doi:10.1016/j.neo.2022.100797 · Cited by 69
“2018 [49] Apc + / 716 Min mice and SPF C57BL/6J mice”
BackgroundWang, N., Wu, S., Huang, L., Hu, Y., He, X., He, J., Hu, B., Xu, Y., Rong, Y., Yuan, C., et al. (2025) · Journal of Biomedical Science · doi:10.1186/s12929-025-01117-x · Cited by 62
“Reports indicate that CRC mouse models with intratumoral colonization of ETBF exhibit elevated levels of IL-17 and increased DNA damage within colonic epithelium, which accelerates tumor growth [77].”
Self-citationGut Microbiota and Colon Cancer: A Role for Bacterial Protein Toxins?
Fiorentini, C., Carlini, F., Germinario, E. A. P., Maroccia, Z., Travaglione, S., & Fabbri, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176201 · Cited by 64
“in the colon and DNA damage in colonic epithelium, with faster tumor onset and greater mortality compared to mice with either bacterial strain alone, suggesting an unexpected link between early CRC and tumorigenic bacteria [79,80,93,94].”
BackgroundEmerging Evidence on the Effects of Dietary Factors on the Gut Microbiome in Colorectal Cancer
Appunni, S., Rubens, M., Ramamoorthy, V., Saxena, A., Tonse, R., McGranaghan, P., Kaiser, A., & Kotecha, R. R. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.718389 · Cited by 68
Diet-derived metabolites and mucus link the gut microbiome to fever after cytotoxic cancer treatment
Schwabkey, Z. I., Wiesnoski, D. H., Chang, C., Tsai, W.-B., Pham, D., Ahmed, S., Hayase, T., Ortega, M. R., El-Himri, R. K., Sanchez, C. A., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abo3445 · Cited by 63
“implicated in other disease settings, including inflammatory bowel disease (28, 33), graft-versus-host disease (34), and colonic epithelial carcinogenesis (35).”
BackgroundCrosstalk between circadian rhythms and the microbiota
Pearson, J. A., Wong, F. S., & Li, W. (2020) · Immunology · doi:10.1111/imm.13278 · Cited by 61
Yang, L., Li, Z., Xie, C.-Y., Fan, J., Lv, J., Xu, X., Lv, J., Kuai, W., & Jia, Y. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i48.7633 · Cited by 65
The Role of DNA Damage Response in Dysbiosis-Induced Colorectal Cancer
Rivas-Domínguez, A., Pastor, N., Martínez-López, L., Colón-Pérez, J., Bermúdez, B., & Orta, M. L. (2021) · Cells · doi:10.3390/cells10081934 · Cited by 67
“The long-term presence of these bacteria, and therefore of BFT, may be related to the pathogenesis of familiar adenomatous polyposis (FAP) contributing to CRC development [152].”
BackgroundThe effect of the intratumoral microbiome on tumor occurrence, progression, prognosis and treatment
Gao, F., Yu, B., Rao, B., Sun, Y. H., Yu, J., Wang, D., Cui, G., & Ren, Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1051987 · Cited by 71
“Other commensal bacteria, such as ETBF and Escherichia coli, have also been shown to be directly associated with colon cancer (88, 89).”
BackgroundInfluentialEmerging applications of upconverting nanoparticles in intestinal infection and colorectal cancer
Singh, R., Dumlupinar, G., Andersson‐Engels, S., & Melgar, S. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s188887 · Cited by 59
“Some of the most commonly associated bacteria with colon cancer includes Fusobacteium nucleatum,(3) Bacteroides fragilis, and Escherichia coli.(4) Inflammatory bowel disease (IBD)-associated colorectal cancer is a classic example of an inflammation-induced cancer form.”
BackgroundToll Like Receptors as Sensors of the Tumor Microbial Dysbiosis: Implications in Cancer Progression
Noci, V. L., Bernardo, G., Bianchi, F., Tagliabue, E., Sommariva, M., & Sfondrini, L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.732192 · Cited by 63
“For example, tumor-coating ETBF has been shown to recruit other bacteria, as well as immune cells, to the tumor site and boosts IL-17-mediated inflammation (Dejea et al., 2018).”
BackgroundBautista, J., Maceiras, M. L., Hidalgo‐Tinoco, C., Guerra-Guerrero, A., Betancourt-Velarde, A., & López‐Cortés, A. (2026) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00883-8 · Cited by 77
Nutraceuticals in colorectal cancer: A mechanistic approach
Rossi, M., Mirbagheri, S., Keshavarzian, A., & Bishehsari, F. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.06.027 · Cited by 64
“coli and Bacteroides fragilis along with a higher expression of their oncotoxins compared to healthy controls (Dejea et al., 2018).”
BackgroundThe Polyamine Spermidine Modulates the Production of the Bacterial Genotoxin Colibactin
Chagneau, C. V., Garcie, C., Bossuet‐Greif, N., Tronnet, S., Brachmann, A. O., Piel, J., Nougayrède, J., Martín, P., & Oswald, É. (2019) · mSphere · doi:10.1128/msphere.00414-19 · Cited by 71
“A synergy between these two bacterial species was observed in tumor formation in an FAP murine model (20).”
BackgroundMolecular Mechanisms Contributing Bacterial Infections to the Incidence of Various Types of Cancer
Sheweita, S. A., & AlSamghan, A. S. (2020) · Mediators of Inflammation · doi:10.1155/2020/4070419 · Cited by 61
“This study indicated an unlikely link between the early colon neoplasia and tumorigenic bacteria [75].”
BackgroundIntratumoral Microbiota as a Target for Advanced Cancer Therapeutics
Peng, F., Hu, M., Su, Z., Hu, L., Guo, L., & Yang, K. (2024) · Advanced Materials · doi:10.1002/adma.202405331 · Cited by 62
Clinical and Genetic Factors to Inform Reducing Colorectal Cancer Disparitites in African Americans
Carethers, J. M. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00531 · Cited by 64
“There is growing evidence that diet and gut microbiome composition greatly influence adenoma and CRC risk (6, 23, 24); however, the data is scant with regards to specific racial differences.”
BackgroundTargeting Gut Microbial Biofilms—A Key to Hinder Colon Carcinogenesis?
Chew, S.-S., Tan, L. T., Law, J. W., Pusparajah, P., Goh, B. H., Mutalib, N. A., & Lee, L. (2020) · Cancers · doi:10.3390/cancers12082272 · Cited by 64
“fragilis on the colonic mucosa of patients with familial adenomatous polyposis (benign precursor lesions) was suggested to accelerate the colon carcinogenesis [8].”
BackgroundKarav, S., Casaburi, G., & Frese, S. A. (2018) · FEBS Open Bio · doi:10.1002/2211-5463.12516 · Cited by 59
The relationship between gastrointestinal cancers and the microbiota
LaCourse, K. D., Johnston, C. D., & Bullman, S. (2021) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(20)30362-9 · Cited by 56
The Guanylate Cyclase C—cGMP Signaling Axis Opposes Intestinal Epithelial Injury and Neoplasia
Rappaport, J. A., & Waldman, S. A. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00299 · Cited by 64
“Fragilis-enriched biofilms, which are absent in normal individuals (138).”
BackgroundThe microbiome(s) and cancer: know thy neighbor(s)
González‐Sánchez, P., & DeNicola, G. M. (2021) · The Journal of Pathology · doi:10.1002/path.5661 · Cited by 62
“coli has been correlated with the development of CRC [113], and its presence was significantly higher in CRC patients compared with healthy controls [114,115].”
BackgroundMicrobiota and Colorectal Cancer: From Gut to Bedside
Silva, M. G., Brunner, V., & Tschurtschenthaler, M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.760280 · Cited by 66
Shine, E. E., & Crawford, J. M. (2021) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-080320-115307 · Cited by 57
Prodrug-conjugated tumor-seeking commensals for targeted cancer therapy
Shen, H., Zhang, C., Li, S., Liang, Y., Lee, L. T., Aggarwal, N., Wun, K. S., Liu, J., Nadarajan, S. P., Weng, C., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48661-y · Cited by 69
Gut Microbiota Influences Experimental Outcomes in Mouse Models of Colorectal Cancer
Leystra, A. A., & Clapper, M. L. (2019) · Genes · doi:10.3390/genes10110900 · Cited by 64
Microbiota-Associated Metabolites and Related Immunoregulation in Colorectal Cancer
Chen, Y., & Chen, Y. (2021) · Cancers · doi:10.3390/cancers13164054 · Cited by 58
Gut microbiota imbalance mediates intestinal barrier damage in high‐altitude exposed mice
Wang, Y., Shi, Y., Li, W., Wang, S., Zheng, J., Xu, G., Li, G., Shen, X., & Yang, J. (2022) · FEBS Journal · doi:10.1111/febs.16409 · Cited by 58
Intratumoral microbiota: A new force in diagnosing and treating pancreatic cancer
Jiang, Z., Zhang, W., Zhang, Z., Sha, G., Wang, D., & Tang, D. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.216031 · Cited by 62
The gut dysbiosis-cancer axis: illuminating novel insights and implications for clinical practice
Asseri, A. H., Bakhsh, T., Abuzahrah, S. S., Ali, S., & Rather, I. A. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1208044 · Cited by 61
“coli led to enhancement in IL-17 levels produced by both γδT17 and Th17 immune cells, therefore, increasing the tumor susceptibility (Dejea et al., 2018).”
BackgroundGarvey, M. (2024) · Biomedicines · doi:10.3390/biomedicines12040740 · Cited by 62
“Mucosal biofilm formation is associated with CRC in sporadic patients and may influence the progression of familial CRC [9].”
BackgroundInfluentialMontanari, E., Bernardo, G., Noci, V. L., Anselmi, M., Pupa, S. M., Tagliabue, E., Sommariva, M., & Sfondrini, L. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02348-0 · Cited by 72
“This close interaction enhances the delivery of colibactin to epithelial cells, significantly increasing the possibility of DNA damage and subsequent tumor development [86].”
Microbe–Mucus Interface in the Pathogenesis of Colorectal Cancer
Coleman, O. I., & Haller, D. (2021) · Cancers · doi:10.3390/cancers13040616 · Cited by 57
“coli to come into close proximity with the intestinal epithelium [100].”
BackgroundResultTan, L., Li, H., Chen, B., Huang, J., Li, Y., Zheng, H., Liu, H., Zhao, Y., & Wang, J. J. (2021) · Food Control · doi:10.1016/j.foodcont.2021.107983 · Cited by 55
Périchon, B., Lichtl-Häfele, J., Bergsten, E., Delage, V., Trieu‐Cuot, P., Sansonetti, P. J., Sobhani, I., & Dramsi, S. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.794391 · Cited by 59
“…bacterial bio fi lms composed mainly of E. coli pks+ and ETBF are found in the mucosa of patients with familial adenomatous polyposis (FAP) and that a synergistic effect of the two toxins ( bft and pks ) driving the development of colon tumor was demonstrated in ApcMin D716/+ (Dejea et al., 2018).”
BackgroundShi, G., Lin, Y., Wu, Y., Zhou, J. C., Cao, L., Chen, J., Li, Y., Tan, N., & Zhong, S. (2022) · Nutrients · doi:10.3390/nu14112199 · Cited by 56
A small molecule inhibitor prevents gut bacterial genotoxin production
Volpe, M. R., Velilla, J. A., Daniel-Ivad, M., Yao, J. J., Stornetta, A., Villalta, P. W., Huang, H., Bachovchin, D. A., Balbo, S., Gaudet, R., et al. (2022) · Nature Chemical Biology · doi:10.1038/s41589-022-01147-8 · Cited by 61
Contribution of pks+ Escherichia coli (E. coli) to Colon Carcinogenesis
Sadeghi, M., Mestivier, D., & Sobhani, I. (2024) · Microorganisms · doi:10.3390/microorganisms12061111 · Cited by 69
“…or healthy controls [19, These activities include thiolation domains (T, thiolation; ACP, Acyl Carrier Protein; PCP, Peptide Carrier Protein) where a thioester bond is formed between the amino acid and the mega synthase; acyltransferase domains for pkss; and adenylation domains for NRPSs. 110,111].”
BackgroundLiu, K., Yang, X., Zeng, M., Yuan, Y., Sun, J., He, P., Sun, J., Xie, Q., Chang, X., Zhang, S., et al. (2021) · Disease Markers · doi:10.1155/2021/1171239 · Cited by 58
“coli adherence, induces increased colonic epithelial cell DNA damage [21].”
BackgroundIntratumoral bacteria are an important “accomplice” in tumor development and metastasis
Wang, G., He, X., & Wang, Q. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188846 · Cited by 52
Association of distinct microbial signatures with premalignant colorectal adenomas
Lee, J. W. J., Plichta, D. R., Asher, S., Delsignore, M., Jeong, T., McGoldrick, J., Staller, K., Khalili, H., Xavier, R. J., & Chung, D. C. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.04.007 · Cited by 51
Wang, Y., Li, Y., Lin, Y., Cao, C.-Y., Chen, D., Huang, X., Li, C., Xu, H., Lai, H., Chen, H., et al. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02413-z · Cited by 70
“This may be driven by Bacteroides fragilis , as colibactin lead to increased IL-17 and DNA damage in colonic tissue and worsens prognosis [200].”
Blandford, L. E., Johnston, E., Sanderson, J. D., Wade, W. G., & Lax, A. J. (2019) · Gut Microbes · doi:10.1080/19490976.2018.1560755 · Cited by 56
Mima, K., Kosumi, K., Baba, Y., Hamada, T., Baba, H., & Ogino, S. (2020) · Human Genetics · doi:10.1007/s00439-020-02235-2 · Cited by 54
Gut microbiota and inflammatory bowel disease
Chen, L., & Wang, J. (2021) · WIREs Mechanisms of Disease · doi:10.1002/wsbm.1540 · Cited by 65
Implications of Gut Microbiota in Complex Human Diseases
Yu, D., Meng, X., de Vos, W. M., Wu, H., Fang, X., & Maiti, A. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312661 · Cited by 56
“The biofilm on the mucosa of Familial Adenomatosis Polyopsis (FAP) patients acts as a marker of CRC [171].”
BackgroundJiang, S., Ma, W., Ma, C., Zhang, Z., Zhang, W., & Zhang, J. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2341717 · Cited by 57
Cruel to Be Kind: Epithelial, Microbial, and Immune Cell Interactions in Gastrointestinal Cancers
Shalapour, S., & Karin, M. (2020) · Annual Review of Immunology · doi:10.1146/annurev-immunol-082019-081656 · Cited by 54
“fragilis cancer-promoting oncotoxins, respectively (120, 121).”
Dissecting Gut‐Microbial Community Interactions using a Gut Microbiome‐on‐a‐Chip
Lee, J., Menon, N. V., & Lim, C. T. (2024) · Advanced Science · doi:10.1002/advs.202302113 · Cited by 60
Xu, H., Wang, Y., Liu, G., Zhu, Z., Shahbazi, M., Reis, R. L., Kundu, S. C., Shi, X., Zu, M., & Xiao, B. (2024) · Advanced Science · doi:10.1002/advs.202410011 · Cited by 74
Tumor microbiome: roles in tumor initiation, progression, and therapy
Zhang, S., Huang, J., Jiang, Z., Tong, H., Ma, X., & Liu, Y. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00248-9 · Cited by 63
The tumor microbiome in cancer progression: mechanisms and therapeutic potential
Zhang, W., Xiang, Y., Ren, H., Liu, Y., Wang, Q., Ran, M., Zhou, W., Lu, T., Zheng, X., Qiao, C., et al. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02403-w · Cited by 64
“E.coli can penetrate the colonic mucosal layer and colonize intestinal polyps, which are potential precursors of cancer, producing an unstable DNA alkyl-ating agent known as colibactin [225].”
Harness the functions of gut microbiome in tumorigenesis for cancer treatment
Lee, M. (2021) · Cancer Communications · doi:10.1002/cac2.12200 · Cited by 50
“In addition, the carcinogenic versions of the bacterial species Escherichia coli and Bacteroides fragilis can generate secreted oncotoxins to cause cancer in Familial adenomatous polyposis (FAP) patients [103].”
BackgroundBartolini, I., Risaliti, M., Ringressi, M. N., Melli, F., Nannini, G., Amedei, A., Muiesan, P., & Taddei, A. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i20.2498 · Cited by 55
Bacterial biofilms as a potential contributor to mucinous colorectal cancer formation
Li, S., Peppelenbosch, M. P., & Smits, R. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.05.009 · Cited by 56
Variations in Oral Microbiota Composition Are Associated With a Risk of Throat Cancer
Wang, L., Yin, G., Guo, Y. Q., Zhao, Y., Zhao, M. M., Lai, Y., Sui, P., Shi, T., Guo, W., & Huang, Z. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00205 · Cited by 54
“Studies have revealed that oral, intestinal, gastric, and throat mucosal layers are colonized by human commensal bacterial populations, which play important roles in human health (Shin et al., 2017; Dejea et al., 2018; Gao L. et al., 2018).”
BackgroundCreekmore, B. C., Gray, J. H., Walton, W. G., Biernat, K. A., Little, M. S., Xu, Y., Liu, J., Gharaibeh, R. Z., & Redinbo, M. R. (2019) · mSystems · doi:10.1128/msystems.00452-19 · Cited by 49
“The bacteria in the gut play a critical role in gastrointestinal homeostasis and disease states and encode specific enzymes that directly influence human health (1, 2).”
Rathje, K., Mortzfeld, B. M., Hoeppner, M. P., Taubenheim, J., Bosch, T. C. G., & Klimovich, A. V. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008375 · Cited by 58
“Several tumors in humans are strongly associated with pathogenicity of a single bacterium, such as Helicobacter pylori [60], or are likely caused by interactions between two commensal bacteria, like Bacteroides fragilis and Escherichia coli [12].”
BackgroundFu, Y., Li, J., Cai, W., Huang, Y., Liu, X., Ma, Z., Tang, Z., Bian, X., Zheng, J., Jiang, J., et al. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.11.018 · Cited by 48
“For example, Dejea et al. 71 have identified patchy bacterial biofilms mainly composed of Escherichia coli and enterotoxigenic Bacteroides fragilis ( B. fragilis) in colonic mucosa of patients with familial adenomatous polyposis, suggesting the close link between colon early neoplasia and tumorigenic…”
BackgroundThe influence of blood on the human gut microbiome
Chénard, T., Malick, M., Dubé, J., & Massé, É. (2020) · BMC Microbiology · doi:10.1186/s12866-020-01724-8 · Cited by 50
“Moreover, enterotoxigenic Bacteroides fragilis [13] and polyketide synthase-producing Escherichia coli [14] have also been reported to promote colorectal cancer by producing DNA damaging molecules such as colobactin [15].”
BackgroundUropathogenic E. coli induces DNA damage in the bladder
Chagneau, C. V., Massip, C., Bossuet‐Greif, N., Fremez, C., Motta, J., Shima, A., Besson‐Fournier, C., Faouder, P. L., Cénac, N., Roth, M., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009310 · Cited by 53
Boleij, A., Fathi, P., Dalton, W. B., Park, B. H., Wu, X., Huso, D. L., Allen, J., Besharati, S., Anders, R. A., Housseau, F., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02014-3 · Cited by 57
Self-citationMicrobiome in cancer progression and therapy
Andreeva, N., Gabbasova, R. R., & Grivennikov, S. I. (2020) · Current Opinion in Microbiology · doi:10.1016/j.mib.2020.09.001 · Cited by 49
Dong, W., Fan, X., Guo, Y., Wang, S., Jia, S., Lv, N., Tao, Y., Pan, Y., Xue, Y., Chen, X., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51864-y · Cited by 60
Lippman, S. M., Abate-Shen, C. T., Maresso, K. C., Colditz, G. A., Dannenberg, A. J., Davidson, N. E., Disis, M. L., DuBois, R. N., Szabo, E. M., Giuliano, A. R., et al. (2018) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-18-0421 · Cited by 52
“Specific strains of gut and intratumoral bacteria induce an immunosuppressive microenvironment favoring oncogenic progression (59).”
BackgroundFoes or Friends? Bacteria Enriched in the Tumor Microenvironment of Colorectal Cancer
Xu, S., Yin, W., Zhang, Y., Lv, Q., Yang, Y., & He, J. (2020) · Cancers · doi:10.3390/cancers12020372 · Cited by 52
“These bacteria include Bacteroides fragili [24], Escherichia coli [24] and Campylobacter jejuni [25], which can secrete B.”
BackgroundOliero, M., Calvé, A., Fragoso, G., Cuisiniere, T., Hajjar, R., Dobrindt, U., & Santos, M. M. (2021) · BMC Cancer · doi:10.1186/s12885-021-07876-8 · Cited by 47
“coli in murine models showed a direct link between colibactin production and colon carcinogenesis [4, 5].”
BackgroundInfluentialSphyris, N., Hodder, M. C., & Sansom, O. J. (2021) · Cancers · doi:10.3390/cancers13051000 · Cited by 52
“fragilis, have also been detected in patients with familial adenomatous polyposis [241].”
BackgroundMicrobiota in cancer: molecular mechanisms and therapeutic interventions
Chen, Z., Guan, D., Wang, Z., Li, X., Dong, S., Huang, J., & Zhou, W. (2023) · MedComm · doi:10.1002/mco2.417 · Cited by 50
“26,47,48 52 Deletion of pks from E. coli NC101 reduced tumor multiplicity and invasion in azoxymethane (AOM)-treated interleukin-10-deficient mice.”
BackgroundHuman-gut-microbiome on a chip
Poceviciute, R., & Ismagilov, R. F. (2019) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0425-0 · Cited by 53
Bacterial biofilm in colorectal cancer: What is the real mechanism of action?
Mirzaei, R., Mirzaei, H., Alikhani, M. Y., Sholeh, M., Arabestani, M. R., Saidijam, M., Karampoor, S., Ahmadyousefi, Y., Moghadam, M. S., Irajian, G. R., et al. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104052 · Cited by 49
Salesse, L., Lucas, C., Hoang, M. H. T., Sauvanet, P., Rézard, A., Rosenstiel, P. C., Damon‐Soubeyrand, C., Barnich, N., Godfraind, C., Dalmasso, G., et al. (2021) · Cancers · doi:10.3390/cancers13092060 · Cited by 55
Cai, W., Chen, X., Men, X., Ruan, H., Hu, M., Liu, S., Lü, T., Liao, J., Zhang, B., Lu, D., et al. (2021) · Science Advances · doi:10.1126/sciadv.abe4827 · Cited by 47
“We notice that many of the bacteria that enriched in the gut microbiota of patients with aCSVD, including p_Proteobacteria (44, 45), p_Actinobacteria (46), g_Escherichia (47), g_Collinsella (48), etc.”
BackgroundGenotoxins: The Mechanistic Links between Escherichia coli and Colorectal Cancer
Wang, Y., & Fu, K. (2023) · Cancers · doi:10.3390/cancers15041152 · Cited by 58
“coli, has been linked to CRC, and colibactin-related mutational signatures were found in CRC patients [21,22].”
Background
Metadata
- Authors
- Dejea, C. M., Fathi, P., Craig, J. M., Boleij, A., Taddese, R., Geis, A. L., Wu, X., DeStefano Shields, C. E., Hechenbleikner, E. M., Huso, D. L., Anders, R. A., Giardiello, F. M., Wick, E. C., Wang, H., Wu, S., Pardoll, D. M., Housseau, F., & Sears, C. L.
- Affiliations
- Johns Hopkins University (US)
- Radboud University Medical Center (NL)
- Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, MD, USA.
- Corresponding author
- Sears, Cynthia L.
- ORCID
- Venue
- Science
- Published
- 2018-02-02
- Volume
- 359
- Issue
- 6375
- Pages
- 592-597
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC5881113
- OpenAlex
- W2786541232
- Cited by
- 1,105
- References
- 17
- Citations by year
- 2026: 119 · 2025: 134 · 2024: 155 · 2023: 128 · 2022: 140 · 2021: 147 · 2020: 117 · 2019: 106 · 2018: 55
- FWCI
- 37.80
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- National Institutes of Health (R01CA151393, K08DK087856, 5T32CA126607, P30DK089502)
- National Cancer Institute (P30CA006973, P50CA62924)
- Alexander and Margaret Stewart Trust (300-2344)
- Bristol Myers Squibb International Immuno-Oncology Network
- Netherlands Organization of Scientific Research (NWO825.11.03, 016.166.089)
- Institute Merieux
- American Society of Colon and Rectal Surgeons (GSRRIG-015)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Keywords
- familial adenomatous polyposis, Escherichia coli, Bacteroides fragilis, colitis-associated colorectal cancer, colonic inflammation, polyps, tumor formation
- MeSH terms
- Gastrointestinal Microbiome, Animals, Bacterial Toxins, Bacteroides fragilis, Colon, Colonic Neoplasms, DNA Damage, Escherichia coli, Humans, Intestinal Mucosa, Metalloendopeptidases, Peptides, Adenomatous Polyposis Coli, Precancerous Conditions, Biofilms, Interleukin-17, Mice, Polyketides, Carcinogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.